Sun Pharmaceuticals to close facility in Detroit

MUMBAI, India — Sun Pharmaceutical Industries last week announced that it notified the Workforce Development Agency for the State of Michigan regarding its decision to stop manufacturing operations and close the Detroit facility, which is located at Elijah McCoy, Detroit, Mich.



The company provided advance written notice of the closure to the employee union and all affected employees. Additionally, it has ensured that the affected employees will be compensated with more than the regular entitlement under the severance package. Employees also will receive other support services.



The company plans to ensure business continuity and avoid market shortage by transferring the manufacturing of products at this location to other units.